Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.

Por um escritor misterioso

Descrição

Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Jumbophage infection is inhibited by the type III CRISPR-Cas system. A.
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Intracellular Organization by Jumbo Bacteriophages
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Huge bacteriophages: bridging the gap? - Brüssow - 2020 - Environmental Microbiology - Wiley Online Library
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A Jumbo Phage Forms a Nucleus-like Compartment to Evade Bacterial Defense Systems
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Subcellular organization of viral particles during maturation of nucleus-forming jumbo phage
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
IJMS, Free Full-Text
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A jumbo phage that forms a nucleus-like structure evades CRISPR–Cas DNA targeting but is vulnerable to type III RNA-based immunity
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection - ScienceDirect
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
IJMS, Free Full-Text
de por adulto (o preço varia de acordo com o tamanho do grupo)